You have no items in your shopping cart.
Human VEGF165 protein
Description
Images & Validation
−
Key Properties
−| Molecular Weight | 19.2 kDa |
|---|---|
| Protein Length | The recombinant human VEGF165 consists of 165 amino acids and predicts a molecular mass of 19.2 KDa. It migrates as an approximately 20 and 22 KDa band in SDS-PAGE under reducing conditions. |
| Protein Sequence | Amino acid sequence derived from human VEGF165 isoform (P15692-4) (Met1-Arg191) was expressed. Human and Cynomolgus VEGF165 sequences are identical. |
| Purity | > 95 % as determined by SDS-PAGE |
Storage & Handling
−| Storage | Lyophilized Human VEGF165 proteinshould be stored desiccated below -20°C. Upon reconstitution, the protein should be stored at 4°C between 2-7 days and for future use below -20°C. For long term storage it is recommended to add a carrier protein (0.62% HSA or BSA). Please prevent freeze-thaw cycles. |
|---|---|
| Form/Appearance | Lyophilized from sterile 100 mM Glycine, 10 mM NaCl, pH 7.0. |
| Expiration Date | 6 months from date of receipt. |
| Hazard Information | The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Human VEGF165 Protein, His Tag, low endotoxin (MALS verified) [orb257924]
Unconjugated
90%
21.1 kDa
1 mg, 50 μgHuman Vascular Endothelial Growth Factor 165 (VEGF165) EasyStep ELISA Kit [orb1950079]
Human
31.25-2000 pg/mL
15 pg/mL
48 T, 96 TRecombinant Human VEGF165 Protein [orb2992805]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 20 KDa. Observed: 18-28 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μgRecombinant Human VEGF165 Protein [orb2995236]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 19.1 KDa. Observed: 18-24 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.
Documents Download
Request a Document
Protocol Information
Human VEGF165 protein (orb3148105)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review






